|
|
Addiction Info Suisse (Ed.). (2010). L'alcool durant la grossesse : informations pour les femmes enceintes, leur partenaire et leur entourage. Lausanne: Addiction Info Suisse.
Keywords: alcohol; target group; woman; pregnancy
|
|
|
|
Menzi, P., Bernhardt Keller, A., Monterrubio Leu, C., & Galgano, M. L. (2010). Hepatitis C : prevention and treatment : a summary of key facts. Berne: Infodrog.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
|
lycaeum.org (Ed.). (1999). Ayahuasca FAQ. Lycaeum.
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances
|
|
|
|
lycaeum.org (Ed.). (1997). Ayahuasca FAQ : contents. Lycaeum.
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances
|
|
|
|
Division Produits chimiques, & Centre suisse d'information toxicologique. (2009). Gamma-hydroxybutyrate (GHB), gamma-butyrolactone (GBL), 1,4-butanediol (BD) : fiche d'information. Berne; Zurich: Office fédéral de la santé publique (OFSP), Division Produits chimiques; Centre suisse d'information toxicologique (CSIT).
Keywords: addiction; chemical addiction; AOD dependence; other AOD substances; gamma-butyrolactone; gamma-hydroxybutyric acid; history; risk; epidemiology; AOD intoxication; first aid; treatment and maintenance; law; drug laws
|
|
|
|
Sezione prodotti chimici, & Centro svizzero d'informazione tossicologica. (2009). Gamma-idrossibutirrato (GHB), gamma-butirrolattone (GBL), 1,4-butandiolo (BD) : scheda informativa. Berna; Zurigo: Ufficio federale della sanità pubblica (UFSP), Sezione prodotti chimici; Centro svizzero d'informazione tossicologica (CSIT).
Keywords: addiction; chemical addiction; AOD dependence; other AOD substances; gamma-butyrolactone; gamma-hydroxybutyric acid; history; risk; epidemiology; AOD intoxication; first aid; treatment and maintenance; law; drug laws
|
|
|
|
Bundesamt für Gesundheit. (2004). Designerdrogen : ein Grundlagenpapier des Bundesamtes für Gesundheit zur nationalen Designerdrogen- und Kokainkonferenz. Bern: Bundesamt für Gesundheit (BAG).
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances; amphetamines; ecstasy; LSD; ketamine; gamma-hydroxybutyric acid; epidemiology; harm reduction; treatment and maintenance; prevention; conference; Switzerland
|
|
|
|
Office fédéral de la santé publique. (2004). Drogues de synthèse : un document de base de l'Office fédéral de la santé publique (OFSP) à l'occasion de la Conférence nationale sur les drogues de synthèse et la cocaïne. Berne: Office fédéral de la santé publique (OFSP).
Keywords: addiction; AOD dependence; chemical addiction; other AOD substances; amphetamines; ecstasy; LSD; ketamine; gamma-hydroxybutyric acid; epidemiology; harm reduction; treatment and maintenance; prevention; conference; Switzerland
|
|
|
|
Office fédéral de la santé publique. (2004). Cocaïne et drogues de synthèse : documents de résumés de thèses de l'Office fédéral de la santé publique à l'occasion de la Conférence nationale sur les drogues de synthèse et la cocaïne. Berne: Office fédéral de la santé publique (OFSP).
Keywords: addiction; AOD dependence; chemical addiction; cocaine; other AOD substances; prevention; primary prevention; secondary prevention; treatment and maintenance; harm reduction; multiple drug use; law enforcement; cooperation; research; evaluation; comorbidity; dual diagnosis; monitoring; target group; physical and chemical analysis and measurement; continuing education; knowledge, attitudes, and practices; government and politics; conference; Switzerland
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction, & European Commission. (2010). The European Union and the drug phenomenon : frequently asked questions. Brochures. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Respect for fundamental rights, protection of public health, well-being, social cohesion and security are the objectives that guide the actions taken by the European Union in the field of illicit drugs. The EU drugs strategy 2005–12 provides the framework for enhanced coordination between action taken at national, EU and international level and commits the members of the EU to tackle illicit drugs by striking a balance between reducing supply and demand. This joint publication between the EMCDDA and the European Commission brings together some of the key frequently asked questions on the EU’s drugs policy and how it functions. Further details can be found via the websites and other links provided at the end of each answer. The brochure exists in English and French language versions.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; public health; public policy on AOD; illicit drug; coordination of activities; law enforcement; Europe; international area
|
|
